CD3 epsilon chain on T-cell receptor complex (CD3ε)

Molecular Classification

Receptor subunit, Immune signaling molecule, Cluster of Differentiation (CD) molecule, Type I transmembrane protein

Other Names

CD3 epsilon, CD3E, T-cell surface glycoprotein CD3 epsilon chain, T3E

Disease Roles

Cancer (targeted in immunotherapies such as bispecific antibodies)Inflammation (role in autoimmunity)Infection (critical for antiviral and antibacterial T cell responses)

CD3 epsilon chain on T-cell receptor complex Overview

CD3 epsilon is an integral membrane protein that forms part of the CD3 complex, a signaling module of the T-cell receptor (TCR) complex. The TCR complex mediates antigen recognition by T cells; the CD3 complex consists of CD3γ, CD3δ, two CD3ε subunits, and a CD3ζ homodimer[1][3][5][6]. CD3ε is essential for coupling antigen recognition by the αβ or γδ TCR heterodimers to intracellular signal transduction via its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM)[4][7]. Upon antigen engagement, CD3ε ITAMs are phosphorylated by Src-family kinases, initiating signaling cascades necessary for T-cell activation, proliferation, and effector function[4][7][8]. CD3ε is a critical therapeutic target for monoclonal antibodies (e.g., muromonab-CD3) used to induce immune modulation in settings such as transplantation, autoimmunity, and cancer[6][8]. Its expression is restricted to T cells, making it a widely used marker for T lymphocytes in diagnostics and research[6][7]. CD3ε’s role in the TCR complex, its essential contribution to immune response, and its clinical utility as a drug target and biomarker make it a cornerstone of immunology and immunotherapy[4][6][7].

Mechanism of Action

Antibody-induced receptor cross-linking and activation Signal initiation via ITAM phosphorylation, leading to downstream T cell activation Immunosuppression or immune activation depending on antibody design and clinical context

Biological Functions

Signal transduction

T-cell activation

T-cell development

Immune response modulation

Disease Associations

Cancer (targeted in immunotherapies such as bispecific antibodies)

Inflammation (role in autoimmunity)

Infection (critical for antiviral and antibacterial T cell responses)

Immunodeficiency (mutations or dysfunction affect T cell function and development)

Safety Considerations

Cytokine release syndrome (CRS) upon anti-CD3ε antibody engagement
Immunosuppression (risk of infection due to T cell depletion)
Off-target activation or depletion of T cells (autoimmunity or immunodeficiency)

Interacting Drugs

Muromonab-CD3 (OKT3, a monoclonal antibody targeting CD3ε)

Blinatumomab (CD3ε-specific bispecific antibody)

Teplizumab (anti-CD3ε antibody)

Otelixizumab (anti-CD3ε)

Associated Biomarkers

Biomarker
CD3ε expression on T cells (for lymphocyte subtyping)
CD3ε occupancy/engagement (as a pharmacodynamic marker in clinical trials of drugs)
T cell activation markers (e.g., CD69, cytokine release)